Tissue microarrays for predictive molecular pathology.
作者信息
Sauter G, Mirlacher M
出版信息
J Clin Pathol. 2002 Aug;55(8):575-6. doi: 10.1136/jcp.55.8.575.
Abstract
摘要
相似文献
1
Tissue microarrays for predictive molecular pathology.用于预测性分子病理学的组织微阵列
J Clin Pathol. 2002 Aug;55(8):575-6. doi: 10.1136/jcp.55.8.575.
2
Tissue microarrays in clinical oncology.临床肿瘤学中的组织微阵列
Semin Radiat Oncol. 2008 Apr;18(2):89-97. doi: 10.1016/j.semradonc.2007.10.006.
3
Quantitative in situ hybridization of tissue microarrays.
Methods Mol Biol. 2006;326:255-64. doi: 10.1385/1-59745-007-3:255.
4
Design, construction, and use of tissue microarrays.组织微阵列的设计、构建及应用
Methods Mol Biol. 2004;264:61-72. doi: 10.1385/1-59259-759-9:061.
5
Tissue microarrays.组织微阵列
Methods Mol Med. 2004;97:377-89. doi: 10.1385/1-59259-760-2:377.
6
Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.组织微阵列（TMA）技术：用于高通量原位研究的小型化病理档案
J Pathol. 2001 Sep;195(1):72-9. doi: 10.1002/path.893.
7
The CINSARC signature: prognostic and predictive of response to chemotherapy?CINSARC 特征：对化疗反应的预后及预测作用？
Cell Cycle. 2010 Oct 1;9(19):4025-7. doi: 10.4161/cc.9.19.13463.
8
From correlation to causality: microarrays, cancer, and cancer treatment.从相关性到因果关系：微阵列、癌症与癌症治疗
Biotechniques. 2003 Mar;Suppl:64-71.
9
Tissue microarrays: potential in the Indian subcontinent.组织微阵列：在印度次大陆的潜力。
Indian J Cancer. 2005 Jan-Mar;42(1):9-14. doi: 10.4103/0019-509x.15094.
10
Accurate confidence aware clustering of array CGH tumor profiles.准确的置信度感知的 array CGH 肿瘤谱聚类。
Bioinformatics. 2010 Jan 1;26(1):6-14. doi: 10.1093/bioinformatics/btp603. Epub 2009 Oct 21.
引用本文的文献
1
Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials.提高提交国家癌症研究所临床试验诊断组织标本实践的方法。
Am J Clin Pathol. 2020 Jan 2;153(2):149-155. doi: 10.1093/ajcp/aqz141.
2
Garbage in, garbage out: a critical evaluation of strategies used for validation of immunohistochemical biomarkers.输入垃圾，输出垃圾：对用于免疫组化生物标志物验证的策略的批判性评估。
Mol Oncol. 2014 Jun;8(4):783-98. doi: 10.1016/j.molonc.2014.03.008. Epub 2014 Mar 21.
3
Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.胃癌浸润前沿中 MMP-7、层粘连蛋白γ2 和 EGFR 表达的临床病理意义。
Gastric Cancer. 2014;17(3):412-22. doi: 10.1007/s10120-013-0302-6. Epub 2013 Sep 19.
4
HER2 in gastric cancer: an immunohistochemical study on tissue microarrays and the corresponding whole-tissue sections with a supplemental fish study.胃 HER2 检测：组织微阵列免疫组化分析及补充 Fish 验证
Pathol Oncol Res. 2013 Oct;19(4):855-65. doi: 10.1007/s12253-013-9654-9. Epub 2013 Jun 26.
5
Cell and tissue microarray technologies for protein and nucleic acid expression profiling.细胞和组织微阵列技术用于蛋白质和核酸表达谱分析。
J Histochem Cytochem. 2013 Feb;61(2):116-24. doi: 10.1369/0022155412470455. Epub 2012 Nov 19.
6
Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections.影响存档福尔马林固定石蜡包埋组织切片降解的因素。
J Histochem Cytochem. 2011 Apr;59(4):356-65. doi: 10.1369/0022155411398488. Epub 2011 Feb 10.
7
Ontology-driven indexing of public datasets for translational bioinformatics.用于转化生物信息学的公共数据集的本体驱动索引编制
BMC Bioinformatics. 2009 Feb 5;10 Suppl 2(Suppl 2):S1. doi: 10.1186/1471-2105-10-S2-S1.
8
[Virtual microscopy in systems pathology].[系统病理学中的虚拟显微镜技术]
Pathologe. 2008 Nov;29 Suppl 2:259-63. doi: 10.1007/s00292-008-1083-2.
9
Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization.利用人类组织芯片和免疫组织化学技术进行核受体相互作用蛋白（NRIP）表达分析，证实其核定位。
J Exp Clin Cancer Res. 2008 Aug 2;27(1):25. doi: 10.1186/1756-9966-27-25.
10
Annotation and query of tissue microarray data using the NCI Thesaurus.使用美国国立癌症研究所术语表对组织微阵列数据进行注释和查询。
BMC Bioinformatics. 2007 Aug 8;8:296. doi: 10.1186/1471-2105-8-296.
本文引用的文献
1
Tissue microarrays: a new approach for quality control in immunohistochemistry.组织微阵列：免疫组织化学质量控制的新方法。
J Clin Pathol. 2002 Aug;55(8):613-5. doi: 10.1136/jcp.55.8.613.
2
Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma.基于组织芯片的荧光原位杂交技术评估乳腺癌中HER-2癌基因的可靠性
J Clin Pathol. 2002 Apr;55(4):315-7. doi: 10.1136/jcp.55.4.315.
3
Tissue microarrays for rapid linking of molecular changes to clinical endpoints.用于将分子变化与临床终点快速关联的组织微阵列。
Am J Pathol. 2001 Dec;159(6):2249-56. doi: 10.1016/S0002-9440(10)63075-1.
4
Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.组织微阵列（TMA）技术：用于高通量原位研究的小型化病理档案
J Pathol. 2001 Sep;195(1):72-9. doi: 10.1002/path.893.
5
Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer.原发性和转移性乳腺癌中her-2/neu基因扩增及过表达模式
J Natl Cancer Inst. 2001 Aug 1;93(15):1141-6. doi: 10.1093/jnci/93.15.1141.
6
High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.
Cancer Res. 2001 Jun 1;61(11):4514-9.
7
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.酪氨酸激酶抑制剂STI571对一名转移性胃肠道间质瘤患者的疗效。
N Engl J Med. 2001 Apr 5;344(14):1052-6. doi: 10.1056/NEJM200104053441404.
8
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.使用重组人源化抗p185HER2/neu单克隆抗体联合顺铂对化疗难治性HER2/neu过表达转移性乳腺癌患者进行受体增强化学敏感性的II期研究。
J Clin Oncol. 1998 Aug;16(8):2659-71. doi: 10.1200/JCO.1998.16.8.2659.
9
Tissue microarrays for high-throughput molecular profiling of tumor specimens.用于肿瘤标本高通量分子分析的组织微阵列。
Nat Med. 1998 Jul;4(7):844-7. doi: 10.1038/nm0798-844.
Zotero 插件